UFP Technologies Inc UFPT
The Company is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. 10-K, Item 1
- Employees
- 4,846
- Headquarters
- Newburyport, MA
- CEO
- R. Jeffrey Bailly
- Next results
- around Feb 23, 2027
Where each dollar of revenue went, FY2025
Revenue of $602.8M through the costs to a net profit of $68.3M · income statement of the 10-K
UFPT among Health care peers
Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.
What changed
35 new risk paragraphs. 10-K filed Feb 27, 2026 against Mar 3, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
10 checks on the latest 10-K. Checks, not verdicts.
0facts worth reading about all 10 checks found nothing to note
-
Receivables -2.1% ($84.7M to $82.9M) vs revenue +19.5% ($504.4M to $602.8M), -21.6 pts apart
-
Cash from operations $91.9M vs net income $68.3M (FY ending Dec 31, 2025)
-
Inventory -0.8% ($87.5M to $86.9M) vs revenue +19.5% ($504.4M to $602.8M), -20.3 pts apart
7 more checks with nothing to note
-
Same auditor in both 10-Ks: GRANT THORNTON LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
35 paragraphs in Risk Factors that were not in the 10-K filed Mar 3, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Mar 3, 2025 10-K, ITEM 1A
Our operating results depend in part on our ability to contain or reduce costs. There is substantial price competition in our industry and upward pressure on material and labor costs. Our success and profitability will depend on our ability to maintain a competitive cost and price structure. Our efforts to maintain and improve…
-
Item 1A · new paragraph · not in the 10-K filed Mar 3, 2025 10-K, ITEM 1A
Based on customer specifications, we are continuously developing new products and improving existing products. Our existing and newly introduced products can contain undetected errors or defects. In addition, these products may not meet
-
Item 1A · new paragraph · not in the 10-K filed Mar 3, 2025 10-K, ITEM 1A
Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards, and other requirements may adversely impact our business and financial results. Laws and regulations in various countries around the world with regards to cybersecurity, privacy and data protection are rapidly…
-
Item 1A · new paragraph · not in the 10-K filed Mar 3, 2025 10-K, ITEM 1A
Even the most well protected IT networks, systems and facilities remain potentially vulnerable because the techniques used in attempted cybersecurity attacks are continually evolving, and may not be recognized until after the attack is launched against a target or, in some instances, are designed not to be detected and, in fact, may not…
New risk paragraphs, against peers
Latest 10-K of each, Health care companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $353.8M | $400.1M | $504.4M | $602.8M |
| Net income | $41.8M | $44.9M | $59.0M | $68.3M |
| Operating cash flow | $17.7M | $41.3M | $66.6M | $91.9M |
| Free cash flow | $4.0M | $30.8M | $56.9M |
Revenue, FY2016 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$602.8M ▲ 19.5% in FY2025$68.3M ▲ 15.8% in FY2025
Recent filings
2 filings in the last 30 days · SEC EDGAR
-
10-QNov 6, 2026Quarterly report (10-Q) period ended Sep 30, 2026
-
8-KNov 3, 2026Quarterly results 8-K item 2.02
About the company
UFP Technologies Inc, Newburyport, MA · from the 10-K filed Feb 27, 2026
The Company is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The Company is a vital link in the medical device supply chain and a valued outsourcing partner to many of the world's top medical device manufacturers. Our single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
- Headquarters
- Newburyport, MA
- Country
- United States
- Reports in
- USD
- Listed on
- Nasdaq
- Fiscal year ends
- December 31
- Last results
- Nov 3, 2026
- Incorporated in
- DE
Employees, at the top of the page: "As of January 24, 2026, the Company had a total of 4,846 full-time employees (compared to 4,146 full-time employees as of January 25, 2025) and 503 temporary workers (compared to 189 temporary workers at January 25, 2025)" (10-K). Address and exchange: SEC's company file.
Email alerts
Sources
The 10-K filed Feb 27, 2026 (open at SEC), compared with the 10-K filed Mar 3, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/UFPT/export.csv") into a cell.